Esplugues J V, Barrachina M D, Calatayud S, Pique J M, Whittle B J
Department of Pharmacology, University of Valencia, Spain.
Br J Pharmacol. 1993 Jan;108(1):9-10. doi: 10.1111/j.1476-5381.1993.tb13431.x.
Bolus injection of interleukin-1 beta (2 micrograms kg-1, i.v.) inhibited acid secretion induced by intravenous infusion of pentagastrin (8 micrograms kg-1 h-1) in the continuously perfused stomach of the anaesthetized rat. Administration of interleukin-1 beta did not modify mean systemic arterial blood pressure. Pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, 2-10 mg kg-1, i.v.), but not dexamethasone (5 mg kg-1, s.c. twice over 16 h), restored the acid secretory responses to pentagastrin. The actions of L-NAME were reversed by the prior administration of L-arginine (100 mg kg-1, i.v.), but not by its enantiomer D-arginine (100 mg kg-1, i.v.). L-NAME (5 mg kg-1, i.v.) increased blood pressure but this was not the mechanism by which interleukin-induced acid inhibition was prevented, since similar systemic pressor responses induced by phenylephrine (10 micrograms kg-1 min-1, i.v.), had no such effect. These findings suggest that interleukin-induced inhibition of acid responses to pentagastrin involves synthesis of NO from L-arginine.
在麻醉大鼠持续灌流的胃中,静脉推注白细胞介素-1β(2微克/千克,静脉注射)可抑制静脉输注五肽胃泌素(8微克/千克·小时)诱导的胃酸分泌。给予白细胞介素-1β不会改变平均体循环动脉血压。用NG-硝基-L-精氨酸甲酯(L-NAME,2 - 10毫克/千克,静脉注射)预处理可恢复对五肽胃泌素的胃酸分泌反应,而地塞米松(5毫克/千克,皮下注射,16小时内分两次)预处理则不能。L-精氨酸(100毫克/千克,静脉注射)可逆转L-NAME的作用,但其对映体D-精氨酸(100毫克/千克,静脉注射)则不能。L-NAME(5毫克/千克,静脉注射)可升高血压,但这不是白细胞介素诱导胃酸抑制的预防机制,因为去氧肾上腺素(10微克/千克·分钟,静脉注射)诱导的类似全身升压反应没有这种作用。这些发现表明,白细胞介素诱导的对五肽胃泌素酸反应的抑制涉及从L-精氨酸合成一氧化氮。